IBDEI33R ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,49550,1,4,0)
 ;;=4^F04.
 ;;^UTILITY(U,$J,358.3,49550,2)
 ;;=^5003051
 ;;^UTILITY(U,$J,358.3,49551,0)
 ;;=F05.^^191^2469^3
 ;;^UTILITY(U,$J,358.3,49551,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49551,1,3,0)
 ;;=3^Delirium d/t Phsyiological Condition
 ;;^UTILITY(U,$J,358.3,49551,1,4,0)
 ;;=4^F05.
 ;;^UTILITY(U,$J,358.3,49551,2)
 ;;=^5003052
 ;;^UTILITY(U,$J,358.3,49552,0)
 ;;=F06.8^^191^2469^6
 ;;^UTILITY(U,$J,358.3,49552,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49552,1,3,0)
 ;;=3^Mental Disorders d/t Physiological Cond
 ;;^UTILITY(U,$J,358.3,49552,1,4,0)
 ;;=4^F06.8
 ;;^UTILITY(U,$J,358.3,49552,2)
 ;;=^5003062
 ;;^UTILITY(U,$J,358.3,49553,0)
 ;;=F32.9^^191^2469^5
 ;;^UTILITY(U,$J,358.3,49553,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49553,1,3,0)
 ;;=3^MDD,Single Episode,Unspec
 ;;^UTILITY(U,$J,358.3,49553,1,4,0)
 ;;=4^F32.9
 ;;^UTILITY(U,$J,358.3,49553,2)
 ;;=^5003528
 ;;^UTILITY(U,$J,358.3,49554,0)
 ;;=R41.82^^191^2469^1
 ;;^UTILITY(U,$J,358.3,49554,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49554,1,3,0)
 ;;=3^Altered Mental Status,Unspec
 ;;^UTILITY(U,$J,358.3,49554,1,4,0)
 ;;=4^R41.82
 ;;^UTILITY(U,$J,358.3,49554,2)
 ;;=^5019441
 ;;^UTILITY(U,$J,358.3,49555,0)
 ;;=R44.3^^191^2469^4
 ;;^UTILITY(U,$J,358.3,49555,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49555,1,3,0)
 ;;=3^Hallucinations,Unspec
 ;;^UTILITY(U,$J,358.3,49555,1,4,0)
 ;;=4^R44.3
 ;;^UTILITY(U,$J,358.3,49555,2)
 ;;=^5019458
 ;;^UTILITY(U,$J,358.3,49556,0)
 ;;=G20.^^191^2470^7
 ;;^UTILITY(U,$J,358.3,49556,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49556,1,3,0)
 ;;=3^Parkinson's Disease
 ;;^UTILITY(U,$J,358.3,49556,1,4,0)
 ;;=4^G20.
 ;;^UTILITY(U,$J,358.3,49556,2)
 ;;=^5003770
 ;;^UTILITY(U,$J,358.3,49557,0)
 ;;=G30.9^^191^2470^1
 ;;^UTILITY(U,$J,358.3,49557,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49557,1,3,0)
 ;;=3^Alzheimer's Disease,Unspec
 ;;^UTILITY(U,$J,358.3,49557,1,4,0)
 ;;=4^G30.9
 ;;^UTILITY(U,$J,358.3,49557,2)
 ;;=^5003808
 ;;^UTILITY(U,$J,358.3,49558,0)
 ;;=G35.^^191^2470^6
 ;;^UTILITY(U,$J,358.3,49558,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49558,1,3,0)
 ;;=3^Multiple Sclerosis
 ;;^UTILITY(U,$J,358.3,49558,1,4,0)
 ;;=4^G35.
 ;;^UTILITY(U,$J,358.3,49558,2)
 ;;=^79761
 ;;^UTILITY(U,$J,358.3,49559,0)
 ;;=G96.9^^191^2470^4
 ;;^UTILITY(U,$J,358.3,49559,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49559,1,3,0)
 ;;=3^Central Nervous System Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,49559,1,4,0)
 ;;=4^G96.9
 ;;^UTILITY(U,$J,358.3,49559,2)
 ;;=^5004200
 ;;^UTILITY(U,$J,358.3,49560,0)
 ;;=G93.1^^191^2470^3
 ;;^UTILITY(U,$J,358.3,49560,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49560,1,3,0)
 ;;=3^Anoxic Brain Damage NEC
 ;;^UTILITY(U,$J,358.3,49560,1,4,0)
 ;;=4^G93.1
 ;;^UTILITY(U,$J,358.3,49560,2)
 ;;=^5004179
 ;;^UTILITY(U,$J,358.3,49561,0)
 ;;=R53.81^^191^2470^5
 ;;^UTILITY(U,$J,358.3,49561,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49561,1,3,0)
 ;;=3^Malaise
 ;;^UTILITY(U,$J,358.3,49561,1,4,0)
 ;;=4^R53.81
 ;;^UTILITY(U,$J,358.3,49561,2)
 ;;=^5019518
 ;;^UTILITY(U,$J,358.3,49562,0)
 ;;=G12.21^^191^2470^2
 ;;^UTILITY(U,$J,358.3,49562,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49562,1,3,0)
 ;;=3^Amyotrophic Lateral Sclerosis
 ;;^UTILITY(U,$J,358.3,49562,1,4,0)
 ;;=4^G12.21
 ;;^UTILITY(U,$J,358.3,49562,2)
 ;;=^6639
 ;;^UTILITY(U,$J,358.3,49563,0)
 ;;=K92.2^^191^2471^7
 ;;^UTILITY(U,$J,358.3,49563,1,0)
 ;;=^358.31IA^4^2
